JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
NQVAX
Price
$54.20
Change
-$0.01 (-0.02%)
Updated
Sep 20 closing price
Ad is loading...

JVMTX vs NQVAX

Header iconJVMTX vs NQVAX Comparison
Open Charts JVMTX vs NQVAXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
Nuveen Multi Cap Value A
Price$54.20
Change-$0.01 (-0.02%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMTX vs NQVAX Comparison Chart
Loading...
VS
JVMTX vs. NQVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and NQVAX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. NQVAX (526M). NQVAX pays higher dividends than JVMTX: NQVAX (0.98) vs JVMTX (0.73). JVMTX was incepted earlier than NQVAX: JVMTX (11 years) vs NQVAX (22 years). JVMTX is a more actively managed with annual turnover of: 41.00 vs. NQVAX (22.00). JVMTX has a lower initial minimum investment than NQVAX: JVMTX (0) vs NQVAX (3000). NQVAX annual gain was more profitable for investors over the last year : 25.08 vs. JVMTX (19.27). NQVAX return over 5 years is better than : 79.12 vs. JVMTX (43.64).
JVMTXNQVAXJVMTX / NQVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years22 years-
Gain YTD11.01016.53467%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B526M4,449%
Annual Yield % from dividends0.730.9874%
Returns for 1 year19.2725.0877%
Returns for 3 years13.3841.3032%
Returns for 5 years43.6479.1255%
Returns for 10 years63.34128.0949%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems